Amplatzer left atrial appendage occlusion: Single center 10-year experience

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 2, 2013, Pages 283-289

  Nietlispach, Fabian ^a   Gloekler, Steffen ^a   Krause, René ^a   Shakir, Samera ^a   Schmid, Michael ^a   Khattab, Ahmed A ^a   Wenaweser, Peter ^a   Windecker, Stephan ^a   Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

device closure; embolism; interventional closure; left atrial appendage; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

AMPLATZER CARDIAC PLUG; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVASCULAR THERAPEUTIC DEVICE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DEVICE EMBOLIZATION; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEFT ATRIAL APPENDAGE OCCLUSION; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

DEVICE CLOSURE; EMBOLISM; INTERVENTIONAL CLOSURE; LEFT ATRIAL APPENDAGE; STROKE;

AGED; AGED, 80 AND OVER; ANESTHESIA, LOCAL; ASPIRIN; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; STROKE; SWITZERLAND; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880619344     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24872     Document Type: Article

References (16)

1. Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D,. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002; 105: 1887-1889.
2. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM,. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60: 417-422.
3. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H,. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005; 46: 9-14.
4. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P,. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009; 374: 534-542.
5. Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minquez JR, Meerkin D, Valdes M, Ormerod O, Leithauser B,. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011; 77: 700-706.
6. Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, Clugston R, Yong G, Gattorna T, Paul V,. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: Initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012; 79: 794-800.
7. Nietlispach F, Gloekler S, Khattab A, Pilgrim T, Schmid M, Wenaweser P, Windecker S, Meier B,. Percutaneous left atrial appendage closure. Eur Geriatr Med 2012; 3: 308-311.
8. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S,. Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011; 123: 417-424.
9. Schmid M, Gloekler S, Saguner AM, Khattab AA, Wahl A, Wenaweser P, Windecker S, Meier B,. Transcatheter left atrial appendage closure in patients with atrial fibrillation: comparison between non-dedicated and dedicated Amplatzer devices. Cardiovasc Med 2012; 16: in print.
10. Meier B,. Catheter-based atrial shunt occlusion, when the going gets even tougher. Catheter Cardiovasc Interv 2007; 69: 21-22.
11. Cruz-Gonzalez I, Martin Moreiras J, Garcia E,. Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device. Catheter Cardiovasc Interv 2011; 78: 970-973.
12. Cardona L, Ana G, Luisa B, Leal A, Antonio F, Lidia S, Cruz FR,. Thrombus formation on a left atrial appendage closure device. Circulation 2011; 124: 1595-1596.
13. Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R, Holmes D, Reddy VY,. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: A PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol 2012; 59: 923-929.
14. Viles-Gonzalez JF, Reddy VY, Petru J, Mraz T, Grossova Z, Kralovec S, Neuzil P,. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. J Interv Card Electrophysiol 2012; 33: 69-75.
15. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
16. Jover E, Roldan V, Gallego P, Hernandez-Romero D, Valdes M, Vicente V, Lip GY, Marin F,. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol 2012; 65: 627-633.